Pancreatic Cancer Research

ResearcherZhengzhou UniversityNo recent work listed

Enze Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-4785-5115; OpenAlex author ID A5100761563. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 2 papers

Papers 2

  1. Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis. Last author DOI 10.1007/s10585-022-10197-0↗
  2. Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc. Co-author DOI 10.3892/ijo.2022.5456↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunjian Wang · 2 shared papers, 2023 · strength 0.42
  2. Luyang Zhang · 2 shared papers, 2023 · strength 0.42
  3. Bo Meng · 1 shared paper, 2023 · strength 0.18
  4. Qiong Li · 1 shared paper, 2023 · strength 0.18
  5. Min Zhang · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.